Comparison of C-Reactive Protein Levels in Traumatic Brain Injury Patients Undergoing Craniotomy With and Without Dexmedetomidine

Summary

Traumatic Brain Injury (TBI) is a major cause of morbidity and mortality and is often associated with a systemic inflammatory response after surgery. C-reactive protein (CRP) is a commonly used biomarker to assess inflammation. Dexmedetomidine is an anesthetic adjuvant that may have anti-inflammatory effects. This study aims to compare C-reactive protein levels in traumatic brain injury patients undergoing craniotomy who receive dexmedetomidine with those who do not receive dexmedetomidine. The study is conducted at Prof. Dr. Margono Soekarjo Regional General Hospital, Purwokerto. The results of this study are expected to provide information on the potential effect of dexmedetomidine on postoperative inflammatory response in traumatic brain injury patients.

Timeline

Start

2025-10-27

Primary completion

2025-10-28

Completion

2025-11-24

Publications

• Background Zhao Y, He J, Yu N, Jia C, Wang S. Mechanisms of Dexmedetomidine in Neuropathic Pain. Front Neurosci. 2020 May 5;14:330. doi: 10.3389/fnins.2020.00330. eCollection 2020.
• Background Xu J, Xiao Q. Assessment of the effects of dexmedetomidine on outcomes of traumatic brain injury using propensity score analysis. BMC Anesthesiol. 2022 Sep 2;22(1):280. doi: 10.1186/s12871-022-01822-2.
• Background Wiles MD. Management of traumatic brain injury: a narrative review of current evidence. Anaesthesia. 2022 Jan;77 Suppl 1:102-112. doi: 10.1111/anae.15608.
• Background Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017 Aug;56(8):893-913. doi: 10.1007/s40262-017-0507-7.
• Background Vitali M, Marasco S, Romenskaya T, Elia A, Longhitano Y, Zanza C, Abenavoli L, Scarpellini E, Bertuccio A, Barbanera A. Decompressive Craniectomy in Severe Traumatic Brain Injury: The Intensivist's Point of View. Diseases. 2023 Jan 30;11(1):22. doi: 10.3390/diseases11010022.
• Background Thapa K, Khan H, Singh TG, Kaur A. Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets. J Mol Neurosci. 2021 Sep;71(9):1725-1742. doi: 10.1007/s12031-021-01841-7. Epub 2021 May 6.
• Background Slupe AM, Kirsch JR. Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection. J Cereb Blood Flow Metab. 2018 Dec;38(12):2192-2208. doi: 10.1177/0271678X18789273. Epub 2018 Jul 16.
• Background Sakti, S., Kriswidyatomo, P. and Sumartono, C. (2025) 'The Effect of Dexmedetomidine on Post-Operative C-Reactive Protein Levels in Patients Undergoing Brain Tumor Resection: A Literature Review', Vascular and Endovascular Review, 8. Available at: www.VERjournal.com
• Background Randall ZD, Brouillard AM, Deych E, Rich MW. Demographic, behavioral, dietary, and clinical predictors of high-sensitivity C-reactive protein: The National Health and Nutrition Examination Surveys (NHANES). Am Heart J Plus. 2022 Aug 27;21:100196. doi: 10.1016/j.ahjo.2022.100196. eCollection 2022 Sep.
• Background Ng SY, Lee AYW. Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets. Front Cell Neurosci. 2019 Nov 27;13:528. doi: 10.3389/fncel.2019.00528. eCollection 2019.
• Background Murdoch I, Surda P, Nguyen-Lu N. Anaesthesia for rhinological surgery. BJA Educ. 2021 Jun;21(6):225-231. doi: 10.1016/j.bjae.2021.02.004. Epub 2021 Mar 23. No abstract available.
• Background Liu X, Li Y, Kang L, Wang Q. Recent Advances in the Clinical Value and Potential of Dexmedetomidine. J Inflamm Res. 2021 Dec 30;14:7507-7527. doi: 10.2147/JIR.S346089. eCollection 2021.
• Background Li Y, He R, Chen S, Qu Y. Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy. Exp Ther Med. 2015 Nov;10(5):1635-1642. doi: 10.3892/etm.2015.2726. Epub 2015 Sep 4.
• Background Kim H. Anesthetic management of the traumatic brain injury patients undergoing non-neurosurgery. Anesth Pain Med (Seoul). 2023 Apr;18(2):104-113. doi: 10.17085/apm.23017. Epub 2023 Apr 28.
• Background Huang Y, Deng Y, Zhang R, Meng M, Chen D. Comparing the Effect of Dexmedetomidine and Midazolam in Patients with Brain Injury. Brain Sci. 2022 Jun 8;12(6):752. doi: 10.3390/brainsci12060752.
• Background Huang CY, Wu SC, Yen YH, Yang JC, Hsu SY, Hsieh CH. Assessing the Predictive Utility of the C-Reactive Protein-to-Lymphocyte Ratio for Mortality in Isolated Traumatic Brain Injury: A Single-Center Retrospective Analysis. Diagnostics (Basel). 2024 Sep 18;14(18):2065. doi: 10.3390/diagnostics14182065.
• Background Hu Y, Zhou H, Zhang H, Sui Y, Zhang Z, Zou Y, Li K, Zhao Y, Xie J, Zhang L. The neuroprotective effect of dexmedetomidine and its mechanism. Front Pharmacol. 2022 Sep 20;13:965661. doi: 10.3389/fphar.2022.965661. eCollection 2022.
• Background Hosseininejad SM, Bozorgi F, Jahanian F, Mohammadian Amiri M, Mohammadpour RA, Hajiaghaei G. C-Reactive Protein and D-dimer as Prognostic Markers for Clinical Outcomes in Patients with Mild Traumatic Brain Injury: A Cross-Sectional Study. Bull Emerg Trauma. 2023;11(3):119-124. doi: 10.30476/BEAT.2023.98573.1435.
• Background Hatfield J, Soto AL, Kelly-Hedrick M, Kaplan S, Komisarow JM, Ohnuma T, Krishnamoorthy V. Safety, Efficacy, and Clinical Outcomes of Dexmedetomidine for Sedation in Traumatic Brain Injury: A Scoping Review. J Neurosurg Anesthesiol. 2024 Apr 1;36(2):101-108. doi: 10.1097/ANA.0000000000000907. Epub 2023 Feb 15.
• Background Haarbauer-Krupa J, Pugh MJ, Prager EM, Harmon N, Wolfe J, Yaffe K. Epidemiology of Chronic Effects of Traumatic Brain Injury. J Neurotrauma. 2021 Dec;38(23):3235-3247. doi: 10.1089/neu.2021.0062. Epub 2021 Aug 17.
• Background Feng X, Ma W, Zhu J, Jiao W, Wang Y. Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway. Mol Med Rep. 2021 Sep;24(3):661. doi: 10.3892/mmr.2021.12300. Epub 2021 Jul 19.
• Background Ding M, Chen Y, Luan H, Zhang X, Zhao Z, Wu Y. Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes. Exp Ther Med. 2019 Sep;18(3):2323-2331. doi: 10.3892/etm.2019.7790. Epub 2019 Jul 18.
• Background Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM, Rosenfeld JV, Park KB. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018 Apr 27;130(4):1080-1097. doi: 10.3171/2017.10.JNS17352. Print 2019 Apr 1.
• Background Department of Nutrition for Health and Development World Health Organization. (2014) C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status, Geneva. Available at: http://apps.who.int/iris/bitstream/10665/133708/1/WHO
• Background Dahlan, M.S. (2019) Besar Sampel dalam Penelitian Kedokteran dan Kesehatan. Jakarta: Epidemiologi Indonesia.
• Background Crowe, G., Atterton, B. and Moran, L. (2022) 'Perioperative Applications of Dexmedetomidine', Anaesthesia Tutorial of The Week [Preprint]. Available at: https://resources.wfsahq.org/anaesthesia-tutorial-of-the-week/.
• Background Chen R, Kang Z, Wang Y, Zhao J, Li S. The Anti-inflammatory Effect of Dexmedetomidine Administration on Patients Undergoing Intestinal Surgery: A Randomized Study. Drugs R D. 2021 Dec;21(4):445-453. doi: 10.1007/s40268-021-00368-x. Epub 2021 Nov 9.
• Background Brodier EA, Cibelli M. Postoperative cognitive dysfunction in clinical practice. BJA Educ. 2021 Feb;21(2):75-82. doi: 10.1016/j.bjae.2020.10.004. Epub 2020 Dec 24. No abstract available.
• Background Bastian, B., Sari, I. and Pratama, F.P. (2022) 'Analysis of C-Reactive Protein (CRP) Levels in Venous and Capillary Blood Samples with Immunoturbidimetric Methods', Medicra (Journal of Medical Laboratory Science/Technology), 5(1), pp. 1-5. Available at: https://doi.org/10.21070/medicra.v5i1.1622.
• Background Bafna U, Sharma P, Singhal RK, Gurjar SS, Bhargava SK. Comparison of hypotensive properties of dexmedetomidine versus clonidine for induced hypotension during functional endoscopic sinus surgery: A randomised, double-blind interventional study. Indian J Anaesth. 2021 Aug;65(8):579-585. doi: 10.4103/ija.IJA_57_21. Epub 2021 Aug 25.
• Background Ayala J, Smith A, F.D. (2006) 'C-reactive protein levels following cardiac surgery in adults', European Journal of Anaesthesiology | EJA, 23, p. 758.
• Background Ali S, Zehra A, Khalid MU, Hassan M, Shah SIA. Role of C-reactive protein in disease progression, diagnosis and management. Discoveries (Craiova). 2023 Dec 31;11(4):e179. doi: 10.15190/d.2023.18. eCollection 2023 Oct-Dec.
• Background Akashi N, Murahata Y, Hosokawa M, Hikasa Y, Okamoto Y, Imagawa T. Cardiovascular and renal effects of constant rate infusions of remifentanil, dexmedetomidine and their combination in dogs anesthetized with sevoflurane. J Vet Med Sci. 2021 Mar 5;83(2):285-296. doi: 10.1292/jvms.20-0457. Epub 2020 Dec 11.

Drugs

Indications